Severe left ventricular systolic dysfunction may reverse with renal transplantation: Uremic cardiomyopathy and cardiorenal syndrome

American Journal of Transplantation

Volumn 8, Issue 11, 2008, Pages 2219-2224

  Zolty, R ^a   Hynes, P J ^b   Vittorio, T J ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Chronic kidney disease (CKD); Congestive heart failure; Posttransplantation; Pretransplantation

Indexed keywords

ALDOSTERONE ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL; CREATININE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ARTERY INTIMA PROLIFERATION; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; CLINICAL FEATURE; CRUSH SYNDROME; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; GEOMETRY; HEART FAILURE; HEART LEFT VENTRICLE CONTRACTION; HUMAN; HYPERTENSION; KIDNEY TRANSPLANTATION; PANCREAS TRANSPLANTATION; POSTOPERATIVE PERIOD; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; RISK FACTOR; SHORT SURVEY; SYSTOLIC DYSFUNCTION; TREATMENT CONTRAINDICATION; UREMIA;

CARDIOMYOPATHIES; HEART DISEASES; HEART VENTRICLES; HUMANS; HYPERTENSION; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; SYNDROME; SYSTOLE; TRANSPLANTATION; TREATMENT OUTCOME; UREMIA; VENTRICULAR DYSFUNCTION, LEFT;

EID: 53749092195     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2008.02407.x     Document Type: Short Survey

References (30)

1. Go AS, Chertow GM, Fan D et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004 351 : 1296 1305.
2. Foley RN, Parfrey PS, Kent GM et al. Long-term evolution of cardiomyopathy in dialysis patients. Kidney Int 1998 54 : 1720 1725.
3. Amann K, Wanner C, Ritz E. Cross-talk between the kidney and the cardiovascular system. J Am Soc Nephrol 2006 17 : 2112 2119.
4. Amann K, Tyralla K, Gross ML et al. Cardiomyocyte loss in experimental renal failure: prevention by ramipril. Kidney Int 2003 63 : 1708 1713.
5. Foley RN, Parfrey PS, Harnett JD et al. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int 1995 47 : 186 192.
6. Harnett JD, Foley RN, Kent GM et al. Congestive heart failure in dialysis patients: Prevalence, incidence, prognosis and risk factors. Kidney Int 1995 47 : 884 890.
7. Vasan RS, Larson MG, Benjamin EJ et al. Left ventricular dilatation and the risk of congestive heart failure in people without myocardial infarction. N Engl J Med 1997 336 : 1350 1355.
8. London GM, Fabiani F, Marchais SJ et al. Uremic cardiomyopathy: An inadequate left ventricular hypertrophy. Kidney Int 1987 31 : 973 980.
9. Weisensee D, Löw-Friedrich I, Riehle M et al. In vitro approach to "uremic cardiomyopathy Nephron 1993 65 : 392 400.
10. Aoki J, Ikari Y, Nakajima H et al. Clinical and pathologic characteristics of dilated cardiomyopathy in hemodialysis patients. Kidney Int 2005 67 : 333 340.
11. Vanholder R, Glorieux G, Lameire N. Uremic toxins and cardiovascular disease. Nephrol Dial Transplant 2003 18 : 463 466.
12. Zoccali C, Bode-Boger S, Mallamaci F et al. Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: A prospective study. Lancet 2001 358 : 2113 2117.
13. Mall G, Huther W, Schneider J et al. Diffuse intermyocardiocytic fibrosis in uremic patients. Nephrol Dial Transplant 1990 5 : 39 44.
14. Converse RL, Jacobson TN, Toto RD et al. Sympathetic overactivity in patients with CRF. N Engl J Med 1992 327 : 1912 1918.
15. Rona G. Catecholamine cardiotoxicity. J Mol Cell Cardiol 1985 17 : 291 306.
16. U.S. Renal Data System : USRDS Annual Data Report (2000): Atlas of end-stage renal disease in the United States. Bethesda, MD : National Institutes of Health, National Institutes of Diabetes and Digestive and Kidney Diseases.
17. Parfrey PS, Foley RN, Harnett JD et al. Outcome and risk factors for left ventricular disorders in chronic uremia. Nephrol Dial Transplant 1996 11 : 1277 1285.
18. Trespalacios FC, Taylor AJ, Agodoa LY et al. Heart failure as a cause for hospitalization in chronic dialysis patients. Am J Kidney Dis 2003 41 : 1267 1277.
19. Cice G, Ferrara L, D'Andrea A et al. Carvedilol increases two-year survival in dialysis patients with dilated cardiomyopathy: A prospective, placebo-controlled trial. J Am Coll Cardiol 2003 41 : 1438 1444.
20. Loghman-Adham M. Medication noncompliance in patients with chronic disease: Issues in dialysis and renal transplantation. Am J Manag Care 2003 9 : 155 171.
21. Sahugn-Sanchez G, Espinola-Zavaleta N, Lafragua-Contreras M et al. The effect of kidney transplant on cardiac function. Echocardiography 2001 18 : 457 462.
22. Melchor JL, Espinoza R, Gracida C. Kidney transplantation in patients with ventricular ejection fraction less than 50 percent: Features and posttransplant outcome. Transplant Proc 2002 34 : 2539 2540.
23. Wali RK, Wang GS, Gottlieb SS et al. Effect of kidney transplantation on left ventricular systolic dysfunction and congestive heart failure in patients with end-stage renal disease. J Am Coll Cardiol 2005 45 : 1051 1060.
24. Abbott KC, Yuan CM, Taylor AJ et al. Early renal insufficiency and hospitalized heart disease after renal transplantation in the era of modern immunosuppression. J am soc Nephrol 2003 14 : 2358 2365.
25. Cirillo M, Lanti MP, Menotti A et al. Definition of kidney dysfunction as a cardiovascular risk factor: Use of urinary albumin excretion and estimated glomerular filtration rate. Arch Intern Med 2008 168 : 617 624.
26. Oppert M, Schneider U, Bocksch W et al. Improvement of left ventricular function and arterial blood pressure 1 year after simultaneous pancreas kidney transplantation. Transplant Proc 2002 34 : 2251 2252.
27. Suh BY, Kwun OS, Kwun KB. Effects of calcium channel blockers in renal allograft patients receiving cyclosporine. Transplant Proc 1998 30 : 3558 3560.
28. Ferreira SR, Moises VA, Tavares A et al. Cardiovascular effects of successful renal transplantation: A 1 year sequential study of left ventricular morphology and function, and 24-hour blood pressure profile. Transplantation 2002 74 : 1580 1587.
29. Guerin AP, Blacher J, Panner B et al. Impact of aortic attenuation on survival of end-stage renal failure. Circulation 2001 103 : 987 992.
30. DeJima JJ, Vieira ML, Viviani LF et al. Long-term impact of renal transplantation on carotid artery properties and on ventricular hypertrophy in end-stage renal failure patients. Nephrol Dial Transplant 2002 17 : 645 651.